We are live on ! Find out more
XTLB

XTL Biopharmaceuticals
XTLB

6 hedge funds and large institutions have $175K invested in XTL Biopharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$42.3K
2
+$774
3
+$526

Top Sellers

1
-$44K
2
-$5.94K
3
-$4.88K
4
Morgan Stanley
Morgan Stanley
New York
-$1.35K
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
1
Noked Israel
Israel
$120K
SP
2
SmartHarvest Portfolios
Washington
$32.2K
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$14.4K
GI
4
GAMMA Investing
California
$8.16K
TRCT
5
Tower Research Capital (TRC)
New York
$588
Morgan Stanley
6
Morgan Stanley
New York
$24
Citadel Advisors
7
Citadel Advisors
Florida
–
XT
8
XTX Topco
Cayman Islands
–